CHEMICAL PROBES OF THE CONFORMATION OF DNA MODIFIED BY CIS-DIAMMINEDICHLOROPLATINUM(II)

被引:74
作者
MARROT, L [1 ]
LENG, M [1 ]
机构
[1] CTR BIOPHYS MOLEC,1A AVE RECH SCI,F-45071 ORLEANS 2,FRANCE
关键词
D O I
10.1021/bi00430a005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:1454 / 1461
页数:8
相关论文
共 43 条
[31]   REACTION OF NUCLEIC-ACIDS WITH CIS-DIAMMINEDICHLOROPLATINUM(II) - INTERSTRAND CROSS-LINKS [J].
RAHMOUNI, A ;
LENG, M .
BIOCHEMISTRY, 1987, 26 (23) :7229-7234
[32]  
RAHMOUNI A, 1988, PLATINUM OTHER METAL, P127
[33]   THE MECHANISM OF ACTION OF PLATINUM ANTITUMOR DRUGS [J].
REEDIJK, J .
PURE AND APPLIED CHEMISTRY, 1987, 59 (02) :181-192
[34]   THE MAJOR ADDUCT OF THE ANTITUMOR DRUG CIS-DIAMMINEDICHLOROPLATINUM(II) WITH DNA BENDS THE DUPLEX BY ALMOST-EQUAL-TO-40-DEGREES TOWARD THE MAJOR GROOVE [J].
RICE, JA ;
CROTHERS, DM ;
PINTO, AL ;
LIPPARD, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (12) :4158-4161
[35]  
Roberts J.J., 1983, MOL ASPECTS ANTICANC, P183
[36]   USE OF EXONUCLEASE-III TO DETERMINE THE SITE OF STABLE LESIONS IN DEFINED SEQUENCES OF DNA - THE CYCLOBUTANE PYRIMIDINE DIMER AND CIS-DICHLORODIAMMINE AND TRANS DICHLORODIAMMINE PLATINUM-II EXAMPLES [J].
ROYERPOKORA, B ;
GORDON, LK ;
HASELTINE, WA .
NUCLEIC ACIDS RESEARCH, 1981, 9 (18) :4595-4609
[37]   CONFORMATIONAL DNA TRANSITION IN THE INVITRO TORSIONALLY STRAINED CHICKEN BETA-GLOBIN 5' REGION [J].
RUNKEL, L ;
NORDHEIM, A .
NUCLEIC ACIDS RESEARCH, 1986, 14 (18) :7143-7158
[38]   X-RAY STRUCTURE OF THE MAJOR ADDUCT OF THE ANTICANCER DRUG CISPLATIN WITH DNA - CIS-[PT(NH3)2(D(PGPG))] [J].
SHERMAN, SE ;
GIBSON, D ;
WANG, AHJ ;
LIPPARD, SJ .
SCIENCE, 1985, 230 (4724) :412-417
[39]  
TRIFONOV EN, 1988, UNUSUAL DNA STRUCTUR, P225
[40]   ETHIDIUM-BROMIDE CHANGES THE NUCLEASE-SENSITIVE DNA-BINDING SITES OF THE ANTI-TUMOR DRUG CIS-DIAMMINEDICHLOROPLATINUM(II) [J].
TULLIUS, TD ;
LIPPARD, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (11) :3489-3492